Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma-Reference-Cited by-同舟云学术

Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma

Published:2018-08-20 Issue:3 Volume:183 Page:428-444
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Seto Anita G.¹,Beatty Xuan¹,Lynch Joshua M.¹,Hermreck Melanie¹,Tetzlaff Michael²,Duvic Madeleine³,Jackson Aimee L.¹^ORCID

Affiliation:

1. miRagen Therapeutics, Inc.; Boulder CO USA

2. Section of Dermatopathology; Department of Pathology; Department of Translational and Molecular Pathology; The University of Texas MD Anderson Cancer Center; Houston TX USA

3. Department of Dermatology; The University of Texas MD Anderson Cancer Center; Houston TX USA

Funder

miRagen Therapeutics, Inc

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15547/fullpdf

Reference71 articles.

1. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells;Babar;Cancer Biology & Therapy,2011

2. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma;Babar;Proceedings of the National Academy of Sciences of the United States of America,2012